UCSF is the lead institution on a new seven-year, $17 million multicenter study to determine if certain immune system cells and/or a drug can be effective in improving and maintaining the long-term health of kidney transplant recipients.
August 04, 2014
July 24, 2014
What: In 2006, more than 6,500 specialists in transplant medicine worldwide gathered for the first time in one location at the World Transplant Congress (WTC) in Boston. Eight years later, the WTC is convening again, this time in San Francisco.
March 10, 2014
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UCSF researchers to specifically weaken immune responses that target transplanted tissue has shown promise.
October 22, 2012
Most liver transplant candidates who died or were removed from the transplant list actually received one or more liver donation offers, according to a recent UCSF study.
October 01, 2012
A $750,000 gift from the John and Marcia Goldman Foundation is spurring a UCSF-led effort to create the first implantable artificial kidney for patients with kidney failure.
October 26, 2011
The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.
February 28, 2011
UCSF has received $48 million from the estate of Nina Ireland, a long-time supporter of UCSF, to further the university’s leadership in studying and treating a host of complex pulmonary conditions.
January 18, 2011
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.